Literature DB >> 21769910

High-precision mass spectrometric analysis using stable isotopes in studies of children.

Henk Schierbeek1, Chris H P van den Akker, Laurent B Fay, Johannes B van Goudoever.   

Abstract

The use of stable isotopes combined with mass spectrometry (MS) provides insight into metabolic processes within the body. Herein, an overview on the relevance of stable isotope methodology in pediatric research is presented. Applications for the use of stable isotopes with MS cover carbohydrate, fat, and amino acid metabolism as well as body composition, energy expenditure, and the synthesis of specific peptides and proteins, such as glutathione and albumin. The main focus of these studies is on the interactions between nutrients and the endogenous metabolism within the body and how these factors affect the health of a growing infant. Considering that the early imprinting of metabolic processes hugely impacts metabolism (and thus functional outcome) later in life, research in this area is important and is advancing rapidly. The major fluxes on a metabolic level are the synthesis and breakdown rates. They can be quantified using kinetic tracer analysis and mathematical modeling. Organic MS and isotope ratio mass spectrometry (IRMS) are the two most mature techniques for the isotopic analysis of compounds. Introduction of the samples is usually done by coupling gas chromatography (GC) to either IRMS or MS because it is the most robust technique for specific isotopic analysis of volatile compounds. In addition, liquid chromatography (LC) is now being used more often as a tool for sample introduction of both volatile and non-volatile compounds into IRMS or MS for (13)C isotopic analyses at natural abundances and for (13)C-labeled enriched compounds. The availability of samples is often limited in pediatric patients. Therefore, sample size restriction is important when developing new methods. Also, the availability of stable isotope-labeled substrates is necessary for measurements of the kinetics and concentrations in metabolic studies, which can be a limiting factor. During the last decade, the availability of these substrates has increased. Furthermore, improvements in the accuracy, precision, and sensitivity of existing techniques (such as GC/IRMS) and the development of new techniques (such as LC/IRMS) have opened up new avenues for tackling these limitations.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21769910     DOI: 10.1002/mas.20344

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  4 in total

1.  The Evaluation and Quantitation of Dihydrogen Metabolism Using Deuterium Isotope in Rats.

Authors:  Radomir Hyspler; Alena Ticha; Henk Schierbeek; Alexander Galkin; Zdenek Zadak
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

2.  Development and validation of a gas chromatography-mass spectrometry method to analyze octanoate enrichments at low concentrations in human plasma.

Authors:  Dewi van Harskamp; Suzan J G Knottnerus; Gepke Visser; Johannes B van Goudoever; Henk Schierbeek
Journal:  Anal Bioanal Chem       Date:  2020-07-09       Impact factor: 4.142

3.  Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula.

Authors:  Stefanie M P Kouwenhoven; Manja Fleddermann; Martijn J J Finken; Jos W R Twisk; Eline M van der Beek; Marieke Abrahamse-Berkeveld; Bert J M van de Heijning; Dewi van Harskamp; Johannes B van Goudoever; Berthold V Koletzko
Journal:  Nutrients       Date:  2021-04-01       Impact factor: 5.717

4.  The effect of short-term high versus normal protein intake on whole-body protein synthesis and balance in children following cardiac surgery: a randomized double-blind controlled clinical trial.

Authors:  Vincent G Geukers; Monique E Dijsselhof; Nicolaas J G Jansen; Johannes M P J Breur; Dewi van Harskamp; Henk Schierbeek; Johannes B van Goudoever; Albert P Bos; Hans P Sauerwein
Journal:  Nutr J       Date:  2015-07-28       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.